London's Telegraph reports that results from a Phase 1 clinical trial evaluating Oxford University's COVID-19 vaccine candidate ChAdOx1 nCoV-19 [ADZ1222 by licensee AstraZeneca (NYSE:AZN)] in healthy volunteers showed that it triggered a "double defense" immune response against the SARS-CoV-2 virus. Researchers noted that administration of the candidate produced both antibodies and killer T cells. The…

Wednesday, July 15th 2020, 11:10 am By: News On 6 Four new virus-related deaths and 1,075 new coronavirus cases were reported in the state since Monday, according to daily numbers released by the Oklahoma State Department of Health.A total of 22,813 Oklahomans have tested positive for COVID-19 and the total number of deaths went up…

San Francisco’s director of public health said Wednesday the rate of transmission of the coronavirus continued to climb in the Bay Area and the city would not move forward with reopening.“Unfortunately we are experiencing a surge in COVID-19 infections that is affecting our community’s health and reopening plans,” Dr. Grant Colfax, the city’s health chief,…

Credit: CC0 Public Domain Researchers from the Penn Institute of Immunology discovered three distinct immune responses to the SARS-CoV2 infection that could help predict the trajectory of disease in severe COVID-19 patients and may ultimately inform how to best treat them. The findings were published in Science. "For patients who are hospitalized with COVID-19, there…

Cities and states across the United States are grappling with how — or even whether — to reopen schools this fall amid the ongoing coronavirus pandemic. But the experiences of other countries around the world suggest an uncomfortable reality: While there are some best practices that can help reduce the risk of spreading the virus,…